[HTML][HTML] Effect of early versus deferred antiretroviral therapy for HIV on survival

…, MJ Gill, RJ Bosch, JN Martin, MB Klein… - … England Journal of …, 2009 - Mass Medical Soc
Background The optimal time for the initiation of antiretroviral therapy for asymptomatic patients
with human immunodeficiency virus (HIV) infection is uncertain. Methods We conducted …

Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society—Lancet Commission

…, P Kasaie, M Kazatchkine, N Kilonzo, M Klag, M Klein… - The Lancet, 2018 - thelancet.com
Inspired by unprecedented improvements in human health and development in recent
decades, our world has embarked on a quest that only a generation ago would have been …

Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America

…, LP Jacobson, MM Kitahata, MB Klein… - Clinical infectious …, 2012 - academic.oup.com
Background. Anal cancer is one of the most common cancers affecting individuals infected
with human immunodeficiency virus (HIV), although few have evaluated rates separately for …

Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada

…, KA Gebo, MJ Gill, A Justice, G Kirk, MB Klein… - PloS one, 2013 - journals.plos.org
Background Combination antiretroviral therapy (ART) has significantly increased survival
among HIV-positive adults in the United States (US) and Canada, but gains in life expectancy …

Rising obesity prevalence and weight gain among adults starting antiretroviral therapy in the United States and Canada

…, MJ Silverberg, J Gill, JE Thorne, M Klein… - AIDS research and …, 2016 - liebertpub.com
The proportion of overweight and obese adults in the United States and Canada has increased
over the past decade, but temporal trends in body mass index (BMI) and weight gain on …

Late presentation for human immunodeficiency virus care in the United States and Canada

KN Althoff, SJ Gange, MB Klein… - Clinical infectious …, 2010 - academic.oup.com
Background . Initiatives to improve early detection and access to human immunodeficiency
virus (HIV) services have increased over time. We assessed the immune status of patients at …

Monkeypox virus infection in humans across 16 countries—April–June 2022

…, D Tan, S Nozza, J Nemeth, MB Klein… - … England Journal of …, 2022 - Mass Medical Soc
Background Before April 2022, monkeypox virus infection in humans was seldom reported
outside African regions where it is endemic. Currently, cases are occurring worldwide. …

Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study

…, H Glans, M Glynn, A Goorhuis, M Klein… - The Lancet Infectious …, 2023 - thelancet.com
Background The early epidemiology of the 2022 monkeypox epidemic in non-endemic countries
differs substantially from the epidemiology previously reported from endemic countries. …

Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial

…, LE Kelly, Y Keynan, K Khwaja, G Klein, M Klein… - Cmaj, 2022 - Can Med Assoc
Background: The role of remdesivir in the treatment of patients in hospital with COVID-19
remains ill defined in a global context. The World Health Organization Solidarity randomized …

Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C Virus–monoinfected patients: a cohort …

…, AR Localio, JK Lim, MB Goetz, MB Klein… - Annals of internal …, 2014 - acpjournals.org
Background: The incidence and determinants of hepatic decompensation have been
incompletely examined among patients co-infected with HIV and hepatitis C virus (HCV) in the …